Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Biochemical Pharmacology|December 3, 2014
Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancerAkaash K Mishra, Silvana S Dormi, Alaina M Turchi, et al.
DNA Repair|January 22, 2008
ATM mediates repression of DNA end-degradation in an ATP-dependent mannerElias A Rahal, Leigh A Henricksen, Yuling Li, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
PARP1 catalytic domain mutations drive high-level resistance to saruparib while preserving DNA damage response vulnerabilitiesMatthew R Jordan, Jessica L Kersey, Joy E Garrett, et al.
Biochemistry|March 19, 2003
RPA phosphorylation in mitosis alters DNA binding and protein-protein interactionsGregory G Oakley, Steve M Patrick, Jiaqin Yao, et al.
Cancers|July 20, 2021
OB-Folds and Genome Maintenance: Targeting Protein-DNA Interactions for Cancer TherapySui Par, Sofia Vaides, Pamela S VanderVere-Carozza, et al.
Molecular and Cellular Biology|March 9, 2002
Partial reconstitution of human DNA mismatch repair in vitro: characterization of the role of human replication protein ACecilia Ramilo, Liya Gu, Shuangli Guo, et al.
Journal of Medicinal Chemistry|September 22, 2017
Design and Structure-Guided Development of Novel Inhibitors of the Xeroderma Pigmentosum Group A (XPA) Protein-DNA InteractionNavnath S Gavande, Pamela VanderVere-Carozza, Akaash K Mishra, et al.
Journal of Nucleic Acids|December 29, 2010
Targeting the OB-Folds of Replication Protein A with Small MoleculesVictor J Anciano Granadillo, Jennifer N Earley, Sarah C Shuck, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Structure-Guided Optimization of Replication Protein A (RPA)-DNA Interaction InhibitorsNavnath S Gavande, Pamela S VanderVere-Carozza, Katherine S Pawelczak, et al.
Pageof 7